90 related articles for article (PubMed ID: 2411071)
1. Fibronectin distribution in nailfold biopsies of scleroderma (systemic sclerosis) patients.
Chen ZY; Maricq HR; Pilia PA; Dobson RL; Silver RM; Ainsworth SK
Acta Derm Venereol; 1985; 65(3):185-9. PubMed ID: 2411071
[TBL] [Abstract][Full Text] [Related]
2. [Distribution of fibronectin in the skin of patients with scleroderma].
Birembaut P; Cahuzac P; Delhomme H; Caron Y; Labat-Robert J; Robert L; Kalis B
Ann Dermatol Venereol; 1982; 109(11):933-7. PubMed ID: 6762839
[TBL] [Abstract][Full Text] [Related]
3. The effect of etretinate on fibronectin in psoriatic skin.
Lauharanta J; Salo O; Kanerva L; Lassus A
Acta Derm Venereol; 1982; 62(4):358-61. PubMed ID: 6183879
[TBL] [Abstract][Full Text] [Related]
4. Immunofluorescence in skin specimens from three different biopsy sites in patients with scleroderma.
Chen ZY; Dobson RL; Ainsworth SK; Silver RM; Rust PF; Maricq HR
Clin Exp Rheumatol; 1985; 3(1):11-6. PubMed ID: 3884202
[TBL] [Abstract][Full Text] [Related]
5. Distribution of fibronectin in diabetic skin.
Leutenegger M; Birembaut P; Poynard JP; Eschard JP; Ricard Y; Caron Y; Robert L; Szendroi M; Labat-Robert J
Pathol Biol (Paris); 1983 Jan; 31(1):45-8. PubMed ID: 6343966
[TBL] [Abstract][Full Text] [Related]
6. Studies on fibronectin in the skin. III. Indirect immunofluorescence studies in lichen planus.
Fyrand O
Acta Derm Venereol; 1979; 59(6):487-92. PubMed ID: 94206
[TBL] [Abstract][Full Text] [Related]
7. Plasma and tissue fibronectin in diabetes.
Labat-Robert J; Leutenegger M; Llopis G; Ricard Y; Derouette JC
Clin Physiol Biochem; 1984; 2(1):39-48. PubMed ID: 6386277
[TBL] [Abstract][Full Text] [Related]
8. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment.
Lee P; Leung FY; Alderdice C; Armstrong SK
J Rheumatol; 1983 Dec; 10(6):930-8. PubMed ID: 6663597
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis.
Lawrence A; Khanna D; Misra R; Aggarwal A
Dermatol Online J; 2006 Jan; 12(1):2. PubMed ID: 16638370
[TBL] [Abstract][Full Text] [Related]
10. Increase in fibronectin in the deep dermis of involved skin in progressive systemic sclerosis.
Cooper SM; Keyser AJ; Beaulieu AD; Ruoslahti E; Nimni ME; Quismorio FP
Arthritis Rheum; 1979 Sep; 22(9):983-7. PubMed ID: 383087
[TBL] [Abstract][Full Text] [Related]
11. Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis.
Davies CA; Herrick AL; Cordingley L; Freemont AJ; Jeziorska M
Rheumatology (Oxford); 2009 Aug; 48(8):876-82. PubMed ID: 19542215
[TBL] [Abstract][Full Text] [Related]
12. [Expression and distribution of type I, III and V collagens in skin lesions from patients with systemic sclerosis].
Liu T; Zhang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):748-52. PubMed ID: 19024305
[TBL] [Abstract][Full Text] [Related]
13. Direct immunofluorescence study in Thai patients with scleroderma.
Kulthanan K; Jiamton S; Taiyaitiang C; Pinkaew S; Suthipinittharm P
J Med Assoc Thai; 2006 Oct; 89(10):1670-6. PubMed ID: 17128843
[TBL] [Abstract][Full Text] [Related]
14. [Fibronectin in the skin of patients with allergic dermatitis].
Roszkiewicz J; Roszkiewicz A; Szarmach H
Przegl Dermatol; 1990; 77(4):233-40. PubMed ID: 2267350
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin. Localization in normal human skin, granulation tissue, hypertrophic scar, mature scar, progressive systemic sclerotic skin, and other fibrosing dermatoses.
Nagata H; Ueki H; Moriguchi T
Arch Dermatol; 1985 Aug; 121(8):995-9. PubMed ID: 3896159
[TBL] [Abstract][Full Text] [Related]
16. The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study.
Soria A; Cario-André M; Lepreux S; Rezvani HR; Pasquet JM; Pain C; Schaeverbeke T; Mahon FX; Taïeb A
Dermatology; 2008; 216(2):109-17. PubMed ID: 18216472
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis.
Salmon-Ehr V; Serpier H; Nawrocki B; Gillery P; Clavel C; Kalis B; Birembaut P; Maquart FX
Arch Dermatol; 1996 Jul; 132(7):802-6. PubMed ID: 8678573
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis.
Preisz K; Sárdy M; Horváth A; Kárpáti S
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):74-9. PubMed ID: 15649195
[TBL] [Abstract][Full Text] [Related]
19. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis.
Davies CA; Jeziorska M; Freemont AJ; Herrick AL
Rheumatology (Oxford); 2006 Nov; 45(11):1349-55. PubMed ID: 17050587
[TBL] [Abstract][Full Text] [Related]
20. Increased pigmentation in scleroderma.
Pope JE; Shum DT; Gottschalk R; Stevens A; McManus R
J Rheumatol; 1996 Nov; 23(11):1912-6. PubMed ID: 8923365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
